Compare Heron Therapeutics Inc (HRTX) vs Nokia Corp (NOK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Nokia Corp — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Nokia Corp trades at $10.18 (market cap $53.00B). The key difference: Nokia Corp is far larger — about 862.2× Heron Therapeutics Inc's market cap, and Nokia Corp pays a 1.73% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | NOK | |
|---|---|---|
Market Cap | $61.47M | $53.00B |
Sector | Health | Technology |
52-Week High | $1.49 | $16.83 |
52-Week Low | $0.32 | $4.13 |
Enterprise Value | $168.21M | $50.95B |
Dividend Yield | — | 1.73% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →
